glp-1 obesity drug news today october 16 2025 What's next for innovation: A primer on the race reshaping pharma and chronic disease care GLP-1 Agonists Market Report 2025-2033,

I will find the way to afford it. she says

Last month, Lilly announced that orforglipron, an orally available GLP-1 treatment, significantly lowered blood glucose levels in patients with type 2 diabetes

PMID 18640588

[DOI] [PubMed] [Google Scholar] Aspnes G

INTRODUCTION Of the 25.8 million Americans with type-2 diabetes mellitus, 7 million of these individuals are unaware that they have the disease

The presence of GLP-1 receptors in testicular tissue and evidence of direct, weight-loss-independent effects on sperm function raises the possibility that GLP-1 drugs may act on male reproductive biology through two distinct mechanisms simultaneously: one systemic (through metabolic improvement) and one local (through direct testicular signaling)